For intellectual property-based companies, like technology and life science companies, planning your financing strategy is essential. Timing your financings in light of upcoming product announcements or design wins, milestones, or trial results may often be the difference between success and failure. In this complimentary series of sessions, Morrison & Foerster partners and guest speakers will focus on the special disclosure considerations and financing approaches that are most significant whether you are planning an IPO or are already a public company.
2:15 p.m. to 2:45 p.m.
Preparing for an IPO for the IP-Based Issuer
2:45 p.m. to 3:15 p.m.
Ongoing Disclosure Issues for IP-Based Companies
3:30 p.m. to 4:00 p.m.
Financing Trends for Tech and Biotech Companies